Your browser doesn't support javascript.
loading
Aminopyridine analogs selectively target metastatic pancreatic cancer.
Smalling, Rana V; Bechard, Matthew E; Duryea, Jeff; Kingsley, Philip J; Roberts, Evan R; Marnett, Lawrence J; Bilbao, Daniel; Stauffer, Shaun R; McDonald, Oliver G.
  • Smalling RV; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Bechard ME; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Duryea J; Department of Pathology and Laboratory Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Kingsley PJ; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Roberts ER; Department of Pathology and Laboratory Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Marnett LJ; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Bilbao D; Department of Pathology and Laboratory Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Stauffer SR; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • McDonald OG; Center for Therapeutics Discovery, Cleveland Clinic, Cleveland, OH, USA.
Oncogene ; 41(10): 1518-1525, 2022 03.
Article en En | MEDLINE | ID: mdl-35031771

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Profármacos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Profármacos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article